About Colgate-Palmolive (NYSE:CL)
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company's oral care products include Colgate Total, Colgate Sensitive Pro-Relief, Colgate Max Fresh and Colgate Optic White. The Company is also engaged in various product categories of the personal care market with operations in liquid hand soap, which it sells under the Palmolive, Protex and Softsoap brands. The Company manufactures and markets a range of products for the home care market, including Palmolive and Ajax dishwashing liquids, Fabuloso and Ajax household cleaners and Murphy's Oil Soap. The Company, through its Hill's Pet Nutrition segment (Hill's), manufactures pet nutrition products for dogs and cats.
Industry, Sector and Symbol
Industry Toilet preparations
Sub-IndustryHousehold Products
SectorConsumer Staples
SymbolNYSE:CL
CUSIP19416210
Phone212-310-2000
Debt
Debt-to-Equity Ratio27.02%
Current Ratio1.36%
Quick Ratio1.00%
Price-To-Earnings
Trailing P/E Ratio23.20
Forward P/E Ratio20.94
P/E Growth2.51
Sales & Book Value
Annual Sales$15.45 billion
Price / Sales3.77
Cash Flow$3.4378 per share
Price / Cash19.37
Book Value$0.28 per share
Price / Book237.82
Profitability
EPS (Most Recent Fiscal Year)$2.87
Net Income$2.02 billion
Net Margins13.10%
Return on Equity1,716.69%
Return on Assets20.17%
Miscellaneous
Employees35,900
Outstanding Shares875,330,000
Colgate-Palmolive (NYSE:CL) Frequently Asked Questions
What is Colgate-Palmolive's stock symbol?
Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."
How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?
Colgate-Palmolive declared a quarterly dividend on Wednesday, March 7th. Shareholders of record on Friday, April 20th will be paid a dividend of $0.42 per share on Tuesday, May 15th. This represents a $1.68 dividend on an annualized basis and a yield of 2.52%. The ex-dividend date of this dividend is Thursday, April 19th. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.40. View Colgate-Palmolive's Dividend History.
How were Colgate-Palmolive's earnings last quarter?
Colgate-Palmolive (NYSE:CL) issued its quarterly earnings results on Friday, January, 26th. The company reported $0.75 EPS for the quarter, hitting analysts' consensus estimates of $0.75. The company had revenue of $3.89 billion for the quarter, compared to the consensus estimate of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The business's revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.75 EPS. View Colgate-Palmolive's Earnings History.
When is Colgate-Palmolive's next earnings date?
What price target have analysts set for CL?
15 brokers have issued 1-year target prices for Colgate-Palmolive's stock. Their predictions range from $66.00 to $85.00. On average, they anticipate Colgate-Palmolive's stock price to reach $77.3333 in the next year. View Analyst Ratings for Colgate-Palmolive.
What are Wall Street analysts saying about Colgate-Palmolive stock?
Here are some recent quotes from research analysts about Colgate-Palmolive stock:
- 1. According to Zacks Investment Research, "Colgate has outperformed the industry in the last three months driven by smooth progress on its savings plan. The company is progressing well with its Global Growth and Efficiency Program along with additional savings anticipated from the recent expansion of the program. Moreover, the company has been infamous with investors for its meet or beat earnings track record. It also remains confident of the brand building and productivity maximization initiatives, which are likely to boost results. However, Colgate has been witnessing strained margins lately due to higher raw material and packaging costs, as well as advertising expenses. Though the company expects improved adjusted gross margin in 2018, it anticipates advertising costs to remain high, which should hurt operating margin. Moreover, it expects the backdrop to remain challenging in 2018. Nonetheless, estimates have been lately stable ahead of first-quarter 2018 earnings release." (4/17/2018)
- 2. Jefferies Group LLC analysts commented, "CL’s 4Q print was disappointing w/org sales of +2% (vs. +3.4% Street) and GM%/OI below expectations. 4Q EPS of $0.75 was in-line with revs/GM% miss partially offset by lower SG&A and $0.02 from taxes. FY18 guide implies tepid low-to-mid single digit % underlying EPS growth (ex-Tax Act/FX benefits), which should augment HPC group GM % worries w/higher commodity costs, constrained pricing, and need for higher investment. We expect CL’s shares to trade down." (1/26/2018)
Who are some of Colgate-Palmolive's key competitors?
Some companies that are related to Colgate-Palmolive include Estée Lauder Companies (EL), Coty (COTY), Pola Orbis Hldg In (PORBF), Hypera Pharma (HYPMY), Edgewell Personal Care (EPC), Mandom (MDOMF), Inter Parfums (IPAR), Revlon (REV), Avon Products (AVP), Eyes Lips Face (ELF), United-Guardian (UG), 2050 Motors (ETFM) and DS Healthcare Group (DSKX).
Who are Colgate-Palmolive's key executives?
Colgate-Palmolive's management team includes the folowing people:
- Ian M. Cook, Chairman of the Board, President, Chief Executive Officer (Age 64)
- Daniel B. Marsili, Chief Human Resource Officer (Age 56)
- John J. Huston, Senior Vice President - Chief of Staff (Age 62)
- Patricia Verduin Ph.D., Chief Technology Officer (Age 58)
- Mukul V. Deoras, Chief Marketing Officer (Age 53)
- Henning I. Jakobsen, Vice President, Corporate Controller (Age 57)
- Victoria L. Dolan, Chief Transformation Officer (Age 57)
- Delia H. Thompson, Chief Investor Relations Officer (Age 67)
- Makarand Karnataki, Company Secretary and Compliance Officer
- Jennifer M. Daniels, Chief Legal Officer and Secretary (Age 53)
Has Colgate-Palmolive been receiving favorable news coverage?
News headlines about CL stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Colgate-Palmolive earned a media sentiment score of 0.12 on Accern's scale. They also gave media coverage about the company an impact score of 47.11 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.
How do I buy shares of Colgate-Palmolive?
Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Colgate-Palmolive's stock price today?
One share of CL stock can currently be purchased for approximately $66.59.
How big of a company is Colgate-Palmolive?
Colgate-Palmolive has a market capitalization of $58.32 billion and generates $15.45 billion in revenue each year. The company earns $2.02 billion in net income (profit) each year or $2.87 on an earnings per share basis. Colgate-Palmolive employs 35,900 workers across the globe.
How can I contact Colgate-Palmolive?
Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]
MarketBeat Community Rating for Colgate-Palmolive (CL)
MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe CL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.
Colgate-Palmolive (NYSE:CL) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
15 Wall Street analysts have issued ratings and price targets for Colgate-Palmolive in the last 12 months. Their average twelve-month price target is $77.3333, suggesting that the stock has a possible upside of 16.13%. The high price target for CL is $85.00 and the low price target for CL is $66.00. There are currently 2 sell ratings, 9 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.13 | 2.13 | 2.24 | 2.24 |
| Ratings Breakdown: | 2 Sell Rating(s)
9 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
9 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
11 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
13 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $77.3333 | $77.4167 | $76.7857 | $76.50 |
| Price Target Upside: | 16.13% upside | 11.20% upside | 5.01% upside | 0.99% upside |
Colgate-Palmolive (NYSE:CL) Consensus Price Target History
Colgate-Palmolive (NYSE:CL) Analyst Ratings History
Show:
(Data available from 4/26/2016 forward)
Colgate-Palmolive (NYSE:CL) Dividend Information
Colgate-Palmolive pays an annual dividend of $1.68 per share, with a dividend yield of 2.52%. CL's next quarterly dividend payment will be made on Tuesday, May 15. The company has grown its dividend for the last 54 consecutive years and is increasing its dividend by an average of 3.80% each year. Colgate-Palmolive pays out 58.54% of its earnings out as a dividend.
| Next Dividend: | 5/15/2018 |
| Annual Dividend: | $1.68 |
| Dividend Yield: | 2.52% |
| Dividend Growth: | 3.80% (3 Year Average) |
| Payout Ratio: | 58.54% (Trailing 12 Months of Earnings)
52.83% (Based on This Year's Estimates)
48.70% (Based on Next Year's Estimates)
|
| Track Record: | 54 Years of Consecutive Dividend Growth |
| Frequency: | Quarterly Dividend |
Colgate-Palmolive (NYSE:CL) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 3/7/2018 | quarterly | $0.42 | 2.41102181400689% | 4/19/2018 | 4/20/2018 | 5/15/2018 |
| 1/11/2018 | quarterly | $0.40 | 2.12% | 1/22/2018 | 1/23/2018 | 2/15/2018 |
| 9/26/2017 | quarterly | $0.40 | 2.19% | 10/20/2017 | 10/23/2017 | 11/15/2017 |
| 6/8/2017 | quarterly | $0.40 | 2.11% | 7/14/2017 | 7/18/2017 | 8/15/2017 |
| 3/9/2017 | quarterly | $0.40 | 2.15% | 4/19/2017 | 4/21/2017 | 5/15/2017 |
| 1/12/2017 | quarterly | $0.39 | 2.37% | 1/19/2017 | 1/23/2017 | 2/15/2017 |
| 9/8/2016 | quarterly | $0.39 | 2.2% | 10/20/2016 | 10/24/2016 | 11/15/2016 |
| 6/9/2016 | quarterly | $0.39 | 2.16% | 7/20/2016 | 7/22/2016 | 8/15/2016 |
| 3/10/2016 | quarterly | $0.39 | 2.28% | 4/20/2016 | 4/22/2016 | 5/16/2016 |
| 1/14/2016 | quarterly | $0.38 | 2.4% | 1/21/2016 | 1/25/2016 | 2/16/2016 |
| 9/10/2015 | quarterly | $0.38 | 2.45% | 10/21/2015 | 10/23/2015 | 11/16/2015 |
| 6/11/2015 | quarterly | $0.38 | 2.29% | 7/21/2015 | 7/23/2015 | 8/14/2015 |
| 2/19/2015 | quarterly | $0.38 | 2.16% | 4/21/2015 | 4/23/2015 | 5/15/2015 |
| 1/8/2015 | quarterly | $0.36 | 2.1% | 1/21/2015 | 1/23/2015 | 2/16/2015 |
| 9/10/2014 | quarterly | $0.36 | 2.24% | 10/15/2014 | 10/17/2014 | 11/14/2014 |
| 6/12/2014 | quarterly | $0.36 | 2.12% | 7/16/2014 | 7/18/2014 | 8/15/2014 |
| 3/13/2014 | quarterly | $0.36 | 2.26% | 4/17/2014 | 4/22/2014 | 5/15/2014 |
| 1/9/2014 | quarterly | $0.34 | 2.09% | 1/22/2014 | 1/24/2014 | 2/14/2014 |
| 9/12/2013 | quarterly | $0.34 | 2.29% | 10/18/2013 | 10/22/2013 | 11/15/2013 |
| 6/20/2013 | quarterly | $0.34 | 2.39% | 7/19/2013 | 7/23/2013 | 8/15/2013 |
| 3/7/2013 | quarterly | $0.68 | 2.35% | 4/19/2013 | 4/23/2013 | 5/15/2013 |
| 1/10/2013 | quarterly | $0.62 | 2.32% | 1/22/2013 | 1/24/2013 | 2/15/2013 |
(Data available from 1/1/2013 forward)
Colgate-Palmolive (NYSE CL) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.02%
Institutional Ownership Percentage: 73.63%
Colgate-Palmolive (NYSE CL) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 4/16/2018 | Daniel B Marsili | Insider | Sell | 19,500 | $71.85 | $1,401,075.00 | 77,935 |  |
| 2/21/2018 | Daniel B Marsili | Insider | Sell | 5,692 | $70.19 | $399,521.48 | 41,677 | |
| 2/20/2018 | Dennis J Hickey | CFO | Sell | 5,651 | $70.18 | $396,587.18 | 413,221 | |
| 2/20/2018 | Ian M Cook | Chairman | Sell | 20,891 | $70.18 | $1,466,130.38 | 1,194,619 | |
| 2/20/2018 | John J Huston | SVP | Sell | 1,524 | $70.17 | $106,939.08 | 87,376 | |
| 2/20/2018 | Justin Skala | COO | Sell | 4,161 | $70.18 | $292,018.98 | | |
| 2/20/2018 | Mukul Deoras | CMO | Sell | 2,572 | $70.19 | $180,528.68 | 39,825 | |
| 2/20/2018 | Patricia Verduin | CTO | Sell | 1,572 | $70.17 | $110,307.24 | 50,675 | |
| 2/13/2018 | Franck J Moison | Vice Chairman | Sell | 44,418 | $69.87 | $3,103,485.66 | 211,048 | |
| 2/13/2018 | John T Cahill | Director | Sell | 7,000 | $69.96 | $489,720.00 | | |
| 2/12/2018 | Mukul Deoras | Insider | Sell | 7,150 | $70.03 | $500,714.50 | | |
| 2/9/2018 | Franck J Moison | Vice Chairman | Sell | 30,000 | $69.70 | $2,091,000.00 | 211,048 | |
| 2/9/2018 | John J Huston | SVP | Sell | 14,000 | $69.44 | $972,160.00 | 100,508 | |
| 2/6/2018 | Franck J Moison | Vice Chairman | Sell | 142,979 | $70.09 | $10,021,398.11 | 224,027 | |
| 2/5/2018 | Henning I Jakobsen | VP | Sell | 36,215 | $71.22 | $2,579,232.30 | 70,783 | |
| 1/31/2018 | Ellen M Hancock | Director | Sell | 4,676 | $74.12 | $346,585.12 | 208,063 | |
| 1/31/2018 | Noel R Wallace | COO | Sell | 126,304 | $73.78 | $9,318,709.12 | 305,631 | |
| 1/9/2018 | Jennifer Daniels | Insider | Sell | 902 | $75.82 | $68,389.64 | 37,788 | |
| 12/13/2017 | Jennifer Daniels | Insider | Sell | 7,375 | $73.18 | $539,702.50 | 38,691 | |
| 11/14/2017 | Victoria L Dolan | Insider | Sell | 9,000 | $73.41 | $660,690.00 | | |
| 11/10/2017 | Mukul Deoras | CMO | Sell | 7,500 | $73.28 | $549,600.00 | 45,217 | |
| 11/9/2017 | Justin Skala | COO | Sell | 126,393 | $72.97 | $9,222,897.21 | 262,361 | |
| 11/9/2017 | Victoria L Dolan | Insider | Sell | 10,000 | $73.07 | $730,700.00 | 60,528 | |
| 11/6/2017 | Stephen I Sadove | Director | Sell | 20,780 | $70.52 | $1,465,405.60 | 36,268 | |
| 8/15/2017 | Patricia Verduin | Insider | Sell | 3,833 | $71.45 | $273,867.85 | 53,173 | |
| 8/10/2017 | John J Huston | SVP | Sell | 14,000 | $71.36 | $999,040.00 | 88,598 | |
| 8/7/2017 | Franck J Moison | Vice Chairman | Sell | 35,000 | $71.52 | $2,503,200.00 | 201,411 | |
| 8/3/2017 | Dennis J Hickey | CFO | Sell | 73,872 | $71.80 | $5,304,009.60 | 484,985 | |
| 8/1/2017 | Ellen M Hancock | Director | Sell | 5,057 | $71.91 | $363,648.87 | 199,777 | |
| 7/27/2017 | John T Cahill | Director | Sell | 8,000 | $72.47 | $579,760.00 | 31,786 | |
| 7/27/2017 | Justin Skala | COO | Sell | 74,374 | $72.51 | $5,392,858.74 | 97,177 | |
| 7/17/2017 | Patricia Verduin | Insider | Sell | 3,833 | $72.41 | $277,547.53 | 53,022 | |
| 6/15/2017 | Patricia Verduin | Insider | Sell | 3,833 | $75.67 | $290,043.11 | 53,022 | |
| 5/10/2017 | John J Huston | SVP | Sell | 14,000 | $71.53 | $1,001,420.00 | 102,838 | |
| 5/8/2017 | Richard J Kogan | Director | Sell | 8,000 | $71.92 | $575,360.00 | 73,065 | |
| 4/17/2017 | Daniel B Marsili | VP | Sell | 14,000 | $73.97 | $1,035,580.00 | 73,904 | |
| 4/17/2017 | Patricia Verduin | Insider | Sell | 3,833 | $73.72 | $282,568.76 | 53,022 | |
| 2/3/2017 | Stephen I Sadove | Director | Sell | 8,000 | $66.00 | $528,000.00 | 33,761 | |
| 1/17/2017 | Patricia Verduin | Insider | Sell | 3,833 | $65.99 | $252,939.67 | 54,924 | |
| 1/9/2017 | Jennifer Daniels | Insider | Sell | 868 | $66.62 | $57,826.16 | 36,813 | |
| 12/15/2016 | Patricia Verduin | Insider | Sell | 3,834 | $65.66 | $251,740.44 | 54,791 | |
| 12/13/2016 | Jennifer Daniels | Insider | Sell | 7,072 | $66.78 | $472,268.16 | 37,463 | |
| 10/17/2016 | Patricia Verduin | Insider | Sell | 3,834 | $72.39 | $277,543.26 | 55,013 | |
| 9/15/2016 | Patricia Verduin | Insider | Sell | 3,834 | $71.85 | $275,472.90 | 55,013 | |
| 8/11/2016 | Franck J Moison | COO | Sell | 15,000 | $75.16 | $1,127,400.00 | 188,029 | |
| 8/10/2016 | John J Huston | SVP | Sell | 14,000 | $74.93 | $1,049,020.00 | 102,761 | |
| 8/10/2016 | Richard J Kogan | Director | Sell | 8,000 | $74.66 | $597,280.00 | 76,065 | |
| 8/8/2016 | Stephen I Sadove | Director | Sell | 8,803 | $74.28 | $653,886.84 | 26,474 | |
| 8/2/2016 | Ellen M Hancock | Director | Sell | 4,584 | $74.82 | $342,974.88 | 203,632 | |
| 8/2/2016 | Noel R Wallace | COO | Sell | 78,849 | $74.69 | $5,889,231.81 | 236,295 | |
| 7/15/2016 | Patricia Verduin | CTO | Sell | 3,666 | $74.98 | $274,876.68 | 54,602 | |
| 6/15/2016 | Patricia Verduin | CTO | Sell | 3,666 | $72.19 | $264,648.54 | 54,602 | |
| 5/16/2016 | Patricia Verduin | CTO | Sell | 3,666 | $71.59 | $262,448.94 | 54,602 | |
| 5/11/2016 | Ellen M Hancock | Director | Sell | 4,566 | $71.85 | $328,067.10 | 199,742 | |
| 5/11/2016 | John J Huston | VP | Sell | 14,000 | $72.23 | $1,011,220.00 | 101,843 | |
| 5/11/2016 | Justin Skala | COO | Sell | 89,200 | $72.17 | $6,437,564.00 | 97,338 | |
| 5/9/2016 | Noel R Wallace | COO | Sell | 8,931 | $72.06 | $643,567.86 | 155,822 | |
| 5/5/2016 | Delia H Thompson | VP | Sell | 40,000 | $72.08 | $2,883,200.00 | 187,673 | |
| 5/3/2016 | John T Cahill | Director | Sell | 16,000 | $72.30 | $1,156,800.00 | 28,696 | |
| 5/3/2016 | Noel R Wallace | COO | Sell | 60,000 | $72.16 | $4,329,600.00 | 204,270 | |
| 5/3/2016 | Victoria L Dolan | VP | Sell | 19,334 | $71.76 | $1,387,407.84 | 55,526 | |
| 4/15/2016 | Patricia Verduin | CTO | Sell | 3,666 | $70.83 | $259,662.78 | 54,602 | |
| 3/8/2016 | Delia H Thompson | VP | Sell | 1,698 | $67.36 | $114,377.28 | 147,673 | |
| 3/8/2016 | Dennis J Hickey | CFO | Sell | 5,420 | $67.36 | $365,091.20 | 387,284 | |
| 3/8/2016 | Franck J Moison | COO | Sell | 6,661 | $67.36 | $448,684.96 | 172,841 | |
| 3/8/2016 | Ian M Cook | CEO | Sell | 25,238 | $67.36 | $1,700,031.68 | 1,281,800 | |
| 3/8/2016 | Mukul Deoras | CMO | Sell | 1,325 | $67.36 | $89,252.00 | 46,866 | |
| 3/8/2016 | Noel R Wallace | Insider | Sell | 5,238 | $67.36 | $352,831.68 | 126,622 | |
| 3/8/2016 | Patricia Verduin | CTO | Sell | 1,953 | $67.36 | $131,554.08 | 50,936 | |
| 2/17/2016 | Dennis J. Hickey | CFO | Sell | 50,697 | $67.05 | $3,399,233.85 | 392,493 | |
| 2/16/2016 | Fabian T. Garcia | COO | Sell | 145,000 | $65.72 | $9,529,400.00 | 117,517 | |
| 2/16/2016 | Patricia Verduin | CTO | Sell | 3,666 | $66.58 | $244,082.28 | 48,068 | |
| 2/11/2016 | John J. Huston | VP | Sell | 14,000 | $64.89 | $908,460.00 | 86,438 | |
| 2/10/2016 | Richard J. Kogan | Director | Sell | 8,000 | $66.27 | $530,160.00 | 68,557 | |
| 2/5/2016 | Delano E Lewis | Director | Sell | 200 | $65.92 | $13,184.00 | 17,920 | |
| 1/15/2016 | Patricia Verduin | CTO | Sell | 3,666 | $62.37 | $228,648.42 | 48,068 | |
| 1/11/2016 | Jennifer Daniels | Insider | Sell | 837 | $62.85 | $52,605.45 | 36,938 | |
| 8/14/2015 | Ellen M Hancock | Director | Sell | 3,637 | $67.89 | $246,915.93 | | |
| 6/15/2015 | Daniel B Marsili | VP | Sell | 14,000 | $65.65 | $919,100.00 | | |
| 6/15/2015 | Patricia Verduin | CTO | Sell | 3,333 | $65.64 | $218,778.12 | | |
| 5/15/2015 | Delano E Lewis | Director | Sell | 6,023 | $68.51 | $412,635.73 | | |
| 4/15/2015 | Daniel B Marsili | VP | Sell | 14,000 | $69.93 | $979,020.00 | | |
| 4/15/2015 | Patricia Verduin | CTO | Sell | 3,333 | $69.89 | $232,943.37 | | |
| 3/9/2015 | Dennis J Hickey | CFO | Sell | 18,224 | $69.49 | $1,266,385.76 | | |
| 3/9/2015 | Fabian T Garcia | COO | Sell | 10,137 | $69.49 | $704,420.13 | | |
| 3/9/2015 | Noel R Wallace | Insider | Sell | 6,638 | $69.49 | $461,274.62 | | |
| 3/9/2015 | Patricia Verduin | CTO | Sell | 2,828 | $69.49 | $196,517.72 | | |
| 3/9/2015 | Victoria L Dolan | VP | Sell | 2,834 | $69.49 | $196,934.66 | | |
| 2/10/2015 | Ellen M Hancock | Director | Sell | 4,011 | $69.38 | $278,283.18 | | |
| 2/10/2015 | John J Huston | VP | Sell | 14,000 | $69.19 | $968,660.00 | | |
| 2/5/2015 | Delano E Lewis | Director | Sell | 9,226 | $69.05 | $637,055.30 | | |
| 1/27/2015 | Andrew D Hendry | Vice Chairman | Sell | 10,000 | $65.29 | $652,900.00 | | |
| 1/15/2015 | Patricia Verduin | CTO | Sell | 3,333 | $68.66 | $228,843.78 | | |
| 12/23/2014 | Andrew D Hendry | Vice Chairman | Sell | 10,000 | $70.39 | $703,900.00 | | |
| 12/15/2014 | Patricia Verduin | CTO | Sell | 3,333 | $68.65 | $228,810.45 | | |
| 11/25/2014 | Andrew D Hendry | Vice Chairman | Sell | 10,000 | $67.94 | $679,400.00 | | |
| 11/25/2014 | Larisa Harrison | Director | Buy | 2,000 | $0.2850 | $570.00 | | |
| 11/17/2014 | Patricia Verduin | CTO | Sell | 3,333 | $67.48 | $224,910.84 | | |
| 11/11/2014 | Andrew D Hendry | Vice Chairman | Sell | 10,000 | $68.46 | $684,600.00 | | |
| 10/29/2014 | Nigel Burton | CMO | Sell | 2,323 | $65.89 | $153,062.47 | | |
| 10/28/2014 | Andrew D Hendry | Vice Chairman | Sell | 10,000 | $66.32 | $663,200.00 | | |
| 9/23/2014 | Andrew D Hendry | Vice Chairman | Sell | 10,000 | $65.50 | $655,000.00 | | |
| 9/15/2014 | Patricia Verduin | CTO | Sell | 3,337 | $64.27 | $214,468.99 | | |
| 9/9/2014 | Andrew D Hendry | Vice Chairman | Sell | 10,000 | $63.52 | $635,200.00 | | |
| 8/18/2014 | Delia H Thompson | VP | Sell | 40,000 | $64.75 | $2,590,000.00 | | |
| 8/18/2014 | Justin Skala | Insider | Sell | 41,525 | $64.52 | $2,679,193.00 | | |
| 8/8/2014 | Franck J Moison | COO | Sell | 24,888 | $64.73 | $1,611,000.24 | | |
| 8/5/2014 | Franck J Moison | COO | Sell | 41,654 | $63.91 | $2,662,107.14 | | |
| 7/22/2014 | Andrew D Hendry | Vice Chairman | Sell | 10,000 | $68.73 | $687,300.00 | | |
| 7/15/2014 | Daniel B Marsili | VP | Sell | 15,500 | $69.71 | $1,080,505.00 | | |
| 7/10/2014 | Patricia Verduin | CTO | Sell | 2,291 | $69.66 | $159,591.06 | | |
| 7/8/2014 | Andrew D Hendry | Vice Chairman | Sell | 10,000 | $68.64 | $686,400.00 | | |
| 6/24/2014 | Andrew D Hendry | Vice Chairman | Sell | 10,000 | $67.72 | $677,200.00 | | |
| 6/16/2014 | Daniel B Marsili | VP | Sell | 15,500 | $67.59 | $1,047,645.00 | | |
| 6/10/2014 | Andrew D Hendry | Vice Chairman | Sell | 6,000 | $68.57 | $411,420.00 | | |
| 5/27/2014 | Andrew D Hendry | Vice Chairman | Sell | 6,000 | $66.90 | $401,400.00 | | |
| 5/15/2014 | Patricia Verduin | CTO | Sell | 2,000 | $66.86 | $133,720.00 | 49,913 | |
| 5/13/2014 | Andrew Hendry | Vice Chairman | Sell | 6,000 | $67.25 | $403,500.00 | 185,726 | |
| 5/13/2014 | Delano Lewis | Director | Sell | 2,100 | $67.19 | $141,099.00 | 23,550 | |
| 5/13/2014 | Dennis Hickey | CFO | Sell | 51,352 | $67.18 | $3,449,827.36 | 360,282 | |
| 5/12/2014 | Daniel Marsili | VP | Sell | 15,500 | $67.37 | $1,044,235.00 | 75,079 | |
| 5/7/2014 | Stephen Fogarty | Insider | Sell | 11,000 | $67.23 | $739,530.00 | 23,809 | |
| 5/2/2014 | Ronald Martin | VP | Sell | 3,000 | $67.13 | $201,390.00 | 7,567 | |
| 5/1/2014 | Delano Lewis | Director | Sell | 5,000 | $67.07 | $335,350.00 | 23,642 | |
| 5/1/2014 | Fabian Garcia | COO | Sell | 122,000 | $67.04 | $8,178,880.00 | 193,936 | |
| 4/22/2014 | Andrew Hendry | Vice Chairman | Sell | 6,000 | $66.89 | $401,340.00 | 185,726 | |
| 4/15/2014 | Patricia Verduin | CTO | Sell | 2,000 | $66.09 | $132,180.00 | 49,913 | |
| 4/8/2014 | Andrew Hendry | Vice Chairman | Sell | 6,000 | $65.03 | $390,180.00 | 185,726 | |
| 3/17/2014 | Patricia Verduin | CTO | Sell | 2,000 | $64.06 | $128,120.00 | 49,913 | |
| 2/28/2014 | Stephen Fogarty | Insider | Sell | 12,000 | $63.10 | $757,200.00 | 23,809 | |
| 1/28/2014 | Andrew Hendry | Vice Chairman | Sell | 6,000 | $62.31 | $373,860.00 | 192,093 | |
| 12/24/2013 | Andrew Hendry | Vice Chairman | Sell | 6,000 | $64.80 | $388,800.00 | 192,093 | |
| 12/16/2013 | Patricia Verduin | CTO | Sell | 2,000 | $64.14 | $128,280.00 | 48,573 | |
| 10/29/2013 | Michael Corbo | VP | Sell | 15,770 | $65.00 | $1,025,050.00 | | |
| 10/29/2013 | Nigel Burton | CMO | Sell | 19,862 | $65.51 | $1,301,159.62 | | |
| 10/29/2013 | Stephen J Fogarty | Insider | Sell | 12,000 | $65.67 | $788,040.00 | | |
| 10/22/2013 | Andrew D Hendry | Vice Chairman | Sell | 6,000 | $62.40 | $374,400.00 | | |
| 10/15/2013 | Patricia Verduin | CTO | Sell | 2,000 | $61.51 | $123,020.00 | | |
| 10/8/2013 | Andrew Hendry | Vice Chairman | Sell | 6,000 | $59.35 | $356,100.00 | 192,547 | |
| 9/24/2013 | Andrew Hendry | Vice Chairman | Sell | 6,000 | $60.00 | $360,000.00 | 192,547 | |
| 9/17/2013 | Michael Corbo | VP | Sell | 1,108 | $59.62 | $66,058.96 | 25,177 | |
| 9/17/2013 | Nigel Burton | CMO | Sell | 2,015 | $59.62 | $120,134.30 | 45,139 | |
| 9/17/2013 | Patricia Verduin | CTO | Sell | 3,649 | $59.71 | $217,881.79 | 48,414 | |
| 9/17/2013 | Stephen Fogarty | Insider | Sell | 1,035 | $59.62 | $61,706.70 | 21,770 | |
| 9/10/2013 | Andrew D Hendry | Vice Chairman | Sell | 6,000 | $58.79 | $352,740.00 | | |
| 8/15/2013 | Franck Moison | COO | Sell | 12,400 | $60.28 | $747,472.00 | 160,538 | |
| 8/15/2013 | Guillenchmidt Alec De | Insider | Sell | 3,888 | $60.28 | $234,368.64 | 99,722 | |
| 8/15/2013 | Patricia Verduin | CTO | Sell | 2,000 | $60.28 | $120,560.00 | 49,872 | |
| 8/12/2013 | Delia Thompson | VP | Sell | 30,950 | $60.73 | $1,879,593.50 | 146,551 | |
| 8/12/2013 | Stephen Fogarty | Insider | Sell | 12,000 | $60.64 | $727,680.00 | 22,725 | |
| 8/8/2013 | Nigel Burton | CMO | Sell | 18,667 | $61.06 | $1,139,807.02 | 46,974 | |
| 8/6/2013 | Elaine Paik | VP | Sell | 7,141 | $60.94 | $435,172.54 | 15,629 | |
| 8/6/2013 | Mukul Deoras | Insider | Sell | 8,417 | $60.90 | $512,595.30 | 30,058 | |
| 7/31/2013 | Ronald T Martin | VP | Sell | 1,800 | $60.27 | $108,486.00 | | |
| 7/30/2013 | Michael Corbo | VP | Sell | 10,000 | $60.21 | $602,100.00 | | |
| 7/15/2013 | Franck J Moison | COO | Sell | 12,400 | $59.05 | $732,220.00 | | |
| 7/15/2013 | Justin Skala | Insider | Sell | 4,822 | $59.03 | $284,642.66 | | |
| 7/15/2013 | Michael Corbo | VP | Sell | 2,000 | $59.13 | $118,260.00 | | |
| 6/17/2013 | Franck J Moison | COO | Sell | 12,400 | $59.18 | $733,832.00 | | |
| 6/17/2013 | Guillenchmidt Alec De | Insider | Sell | 3,888 | $59.09 | $229,741.92 | | |
| 6/17/2013 | Michael Corbo | VP | Sell | 2,000 | $59.09 | $118,180.00 | | |
| 6/4/2013 | Andrew D Hendry | Vice Chairman | Sell | 4,000 | $58.84 | $235,360.00 | | |
| 5/21/2013 | Andrew D Hendry | Vice Chairman | Sell | 6,000 | $61.63 | $369,780.00 | | |
| 5/15/2013 | Franck J Moison | COO | Sell | 6,200 | $122.66 | $760,492.00 | | |
| 5/15/2013 | Guillenchmidt Alec De | Insider | Sell | 1,944 | $122.66 | $238,451.04 | | |
| 5/15/2013 | Michael Corbo | VP | Sell | 1,000 | $122.66 | $122,660.00 | | |
| 5/13/2013 | Rosemary Nelson | VP | Sell | 14,000 | $121.00 | $1,694,000.00 | | |
| 5/10/2013 | Dennis J Hickey | CFO | Sell | 64,000 | $120.54 | $7,714,560.00 | | |
| 5/7/2013 | Andrew D Hendry | Vice Chairman | Sell | 6,000 | $120.37 | $722,220.00 | | |
| 4/30/2013 | Nigel Burton | CMO | Sell | 80,334 | $118.68 | $9,534,039.12 | | |
| 2/26/2013 | Daniel B Marsili | VP | Sell | 12,252 | $113.66 | $1,392,562.32 | | |
| 2/26/2013 | Justin Skala | Insider | Sell | 5,894 | $113.64 | $669,794.16 | | |
| 12/4/2012 | Andrew D Hendry | Vice Chairman | Sell | 6,000 | $108.00 | $648,000.00 | | |
| 10/2/2012 | Andrew D Hendry | Vice Chairman | Sell | 6,000 | $108.27 | $649,620.00 | | |
| 9/4/2012 | Andrew D Hendry | Vice Chairman | Sell | 6,000 | $106.16 | $636,960.00 | | |
(Data available from 1/1/2013 forward)
Colgate-Palmolive (NYSE CL) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Colgate-Palmolive (CL) call put ratio 5.8 calls to 1 put into EPS and outlook
www.streetinsider.com - April 26 at 8:30 AM |
 | Why Colgate-Palmolive (CL) Might Surprise This Earnings Season
www.nasdaq.com - April 25 at 5:18 PM |
| Colgate-Palmolive Enters Oversold Territory (CL)
www.nasdaq.com - April 25 at 5:18 PM |
| Colgate-Palmolive (CL) call put ratio 1 call to 6 puts with focus on April 67 puts into Q1
www.streetinsider.com - April 24 at 8:34 AM |
 | What Analysts Recommend For Church & Dwight Stock
finance.yahoo.com - April 23 at 5:02 PM |
| 20 Earnings Reports to Watch for This Week
finance.yahoo.com - April 23 at 8:27 AM |
| Does Colgate-Palmolive Company’s (NYSE:CL) PE Ratio Signal A Selling Opportunity?
finance.yahoo.com - April 22 at 6:20 PM |
 | Colgate-Palmolive (CL) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - April 22 at 5:34 PM |
| Contrasting Colgate-Palmolive (CL) & Inter Parfums (IPAR)
www.americanbankingnews.com - April 21 at 11:16 PM |
 | Global Dog and Cat Food Market 2018-2022 - Key Vendors are Colgate-Palmolive, General Mills, Mars, Neste & The ...
www.businesswire.com - April 20 at 5:10 PM |
| Colgate-Palmolive (CL) PT Lowered to $80.00 at Morgan Stanley
www.americanbankingnews.com - April 20 at 10:25 AM |
| Colgate-Palmolive (CL) call put ratio 1 call to 2.8 puts with focus on April 70 and 70.50 puts
www.streetinsider.com - April 20 at 8:41 AM |
| Colgate-Palmolive (CL) Set to Announce Quarterly Earnings on Friday
www.americanbankingnews.com - April 20 at 1:20 AM |
| Colgate-Palmolive (CL) Downgraded to "Strong Sell" at BidaskClub
www.americanbankingnews.com - April 19 at 11:03 AM |
| Insider Selling: Colgate-Palmolive (CL) Insider Sells 19,500 Shares of Stock
www.americanbankingnews.com - April 18 at 7:16 PM |
| Colgate-Palmolive Company (CL) Ex-Dividend Date Scheduled for April 19, 2018
www.nasdaq.com - April 18 at 5:32 PM |
| Colgate-Palmolive's (CL) Hold Rating Reiterated at Stifel Nicolaus
www.americanbankingnews.com - April 18 at 11:10 AM |
| EX-Dividend Schedule: Colgate-Palmolive Raised its Dividend By 5%; Will Trade Ex-Dividend on April 19, 2018
finance.yahoo.com - April 18 at 8:32 AM |
| Ex-Dividend Reminder: Procter & Gamble, Ford Motor and Colgate-Palmolive
www.nasdaq.com - April 17 at 5:42 PM |
| Colgate-Palmolive (CL) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - April 17 at 12:47 PM |
| Analysts Anticipate Colgate-Palmolive (CL) Will Post Quarterly Sales of $4.01 Billion
www.americanbankingnews.com - April 17 at 4:53 AM |
| Colgate-Palmolive's (CL) Hold Rating Reiterated at Deutsche Bank
www.americanbankingnews.com - April 16 at 9:17 PM |
| Jefferies Group Reaffirms "Hold" Rating for Colgate-Palmolive (CL)
www.americanbankingnews.com - April 16 at 9:17 PM |
| Colgate-Palmolive (CL) Shares Cross Above 200 DMA
www.nasdaq.com - April 16 at 5:09 PM |
| Zacks Investment Research Lowers Colgate-Palmolive (CL) to Sell
www.americanbankingnews.com - April 15 at 7:19 PM |
| Zacks: Brokerages Anticipate Colgate-Palmolive (CL) Will Announce Earnings of $0.73 Per Share
www.americanbankingnews.com - April 15 at 3:08 AM |
| Colgate-Palmolive Webcasts 2018 First Quarter Earnings Conference Call April 27, 2018 – 11:00 am ET
www.businesswire.com - April 13 at 5:17 PM |
| Partner of the Year Award for the Eighth Consecutive Year
www.businesswire.com - April 12 at 5:20 PM |
| Colgate-Palmolive Earns 2018 ENERGY STAR® Partner of the Year Award for the Eighth Consecutive Year
finance.yahoo.com - April 12 at 5:20 PM |
| Colgate-Palmolive (CL) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - April 8 at 2:38 PM |
| Colgate-Palmolive (CL) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - April 6 at 8:45 PM |
| Colgate-Palmolive (CL) Lowered to "Sell" at Zacks Investment Research
www.americanbankingnews.com - April 6 at 11:11 AM |
 | Morning Technical Insight on these Personal Products Stocks -- Avon Products, Colgate-Palmolive, Estee Lauder, and ...
www.prnewswire.com - April 6 at 8:47 AM |
| Stifel Nicolaus Reiterates "$73.00" Price Target for Colgate-Palmolive (CL)
www.americanbankingnews.com - April 4 at 4:44 PM |
 | Should You Buy Colgate-Palmolive And Its Consecutive Years Of Dividend Growth?
seekingalpha.com - April 4 at 4:00 PM |
| Colgate-Palmolive (CL) PT Lowered to $76.00 at Jefferies Group
www.americanbankingnews.com - April 4 at 1:20 PM |
| Morgan Stanley cuts estimates on consumer products majors
seekingalpha.com - April 4 at 8:38 AM |
| Morgan Stanley Lowers Colgate-Palmolive (CL) Price Target to $83.00
www.americanbankingnews.com - April 2 at 8:42 PM |
| Colgate-Palmolive (CL) PT Lowered to $75.00
www.americanbankingnews.com - April 2 at 12:30 AM |
| Colgate-Palmolive (CL) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - March 30 at 1:14 PM |
| $0.74 EPS Expected for Colgate-Palmolive (CL) This Quarter
www.americanbankingnews.com - March 29 at 5:12 AM |
| Colgate-Palmolive (CL) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - March 28 at 2:06 PM |
| Is Colgate-Palmolive A Buy At 52-Week Lows?
seekingalpha.com - March 27 at 8:48 AM |
| See what the IHS Markit Score report has to say about Colgate-Palmolive Co.
finance.yahoo.com - March 27 at 8:47 AM |
| Quantitative Analysis Of Colgate-Palmolive: Given The Recent Decline In Price, Is It Now A Good Value?
seekingalpha.com - March 24 at 5:03 PM |
| On World Water Day 2018, Colgate Asks People To Turn Off The Faucet While Brushing
finance.yahoo.com - March 23 at 5:25 PM |
| S&P 500 Movers: AFL, CL - Nasdaq
www.nasdaq.com - March 21 at 9:18 AM |
| Colgate-Palmolive (CL), Estee Lauder (EL) on Watch Amid Rumors - StreetInsider.com
www.streetinsider.com - March 21 at 9:18 AM |
| Colgate Continues to Recommend Shareholders Reject “Mini-Tender” Offer by Baker Mills LLC Following Increase in Number of Shares Sought
finance.yahoo.com - March 19 at 5:05 PM |
| LVMH Moet Hennessy Louis Vuitton (LVMUY) vs. Colgate-Palmolive (CL) Head to Head Analysis
www.americanbankingnews.com - March 19 at 7:45 AM |
Colgate-Palmolive (NYSE:CL) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Colgate-Palmolive (NYSE:CL) Income Statement, Balance Sheet and Cash Flow Statement
Colgate-Palmolive (NYSE CL) Stock Chart for Thursday, April, 26, 2018
Loading chart…
